Akero Therapeutics Inc (AKRO)
25.33
+0.85
(+3.47%)
USD |
NASDAQ |
Mar 28, 14:55
Akero Therapeutics Total Assets (Quarterly): 580.27M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 580.27M |
September 30, 2023 | 635.33M |
June 30, 2023 | 663.81M |
March 31, 2023 | 348.82M |
December 31, 2022 | 356.57M |
September 30, 2022 | 379.41M |
June 30, 2022 | 185.68M |
March 31, 2022 | 169.89M |
December 31, 2021 | 195.55M |
September 30, 2021 | 223.53M |
June 30, 2021 | 238.01M |
Date | Value |
---|---|
March 31, 2021 | 257.62M |
December 31, 2020 | 273.34M |
September 30, 2020 | 300.04M |
June 30, 2020 | 114.06M |
March 31, 2020 | 126.62M |
December 31, 2019 | 138.12M |
September 30, 2019 | 150.14M |
June 30, 2019 | 163.17M |
March 31, 2019 | 72.07M |
December 31, 2018 | 77.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
72.07M
Minimum
Mar 2019
663.81M
Maximum
Jun 2023
278.60M
Average
230.77M
Median
Total Assets (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 640.55M |
89bio Inc | 596.27M |
Viking Therapeutics Inc | 368.49M |
Eli Lilly and Co | 64.01B |
Ionis Pharmaceuticals Inc | 2.990B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 44.96M |
Shareholders Equity (Quarterly) | 535.31M |